InflaRx (IFRX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on InflaRx (IFRX) is Neutral.

The composite score behind that read is -0.08, weighing +0.08 of bullish evidence against -0.23 bearish.

InflaRx last closed at $1.59, -0.63% on the session.

Against the IVW growth benchmark the position is -0.20% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

18 graded predictions for IFRX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks InflaRx in the 16th percentile on return on equity, where 100 is best.

InflaRx is classified under Health Care / Biotechnology, with a market capitalisation of $235.79M.

StockMap tracks InflaRx as the 239th largest of the 386 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 307 Neutral, 66 Moderate Underperform and 13 Moderate Outperform.

On that composite InflaRx ranks 188th of 386 in the group, against a group median of -0.08.